Five years after the COVID-19 pandemic, you're likely a pro at the basics—masks when needed, immune support and staying current on booster shots. But as sick season rolls around, you might be ...
I was addicted to Afrin nasal spray for a decade — I couldn’t breathe without it, how I finally quit
Get a whiff of this nightmare. A young woman struggled for years to breathe freely after becoming hooked on a popular over-the-counter nasal spray — making it nearly impossible to quit. “I could not ...
A “BUY” Rating for Aya Gold & Silver Inc. This article recommends a BUY rating for Aya Gold & Silver Inc. (TSX:AYA:CA), a stock listed on the TSX exchange. This represents an upside from our previous ...
Vaccines are usually administered with a needle poke into the arm. But what if instead of a poke, you could get vaccinated with a huff and a puff? Administered through the nose, nasal vaccines are ...
This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. While pregnant with her third child ...
COUNTY REGIONAL POLICE STATION, NOW COVERING ARMSTRONG COUNTY. INVESTIGATORS SAY THEY HAVE FOUND A FOURTH DEAD INFANT IN THE HOME OF JESSICA MOTH. SHE WAS RENTING A HOME IN CADOGAN TOWNSHIP, WHERE ...
What Is Enbumyst, and Why Does It Matter? Enbumyst is a new nasal spray form of bumetanide (first approved by the FDA in 1983). It is a type of medicine called a loop diuretic (also known as a “water ...
Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in ...
Forty-two years after approving the potent diuretic Bumex (bumetanide) as both an oral and infused treatment for edema, the FDA has endorsed a new version of the drug to be delivered as a nasal spray.
Edema and fluid overload remain the leading causes of hospitalization and readmission for patients with CHF, cirrhosis, and chronic kidney disease. An estimated 6.7 million Americans live with heart ...
The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent a common and costly issue that results in more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback